These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7421893

  • 1. Decreased risk of endometrial cancer among oral-contraceptive users.
    Kaufman DW, Shapiro S, Slone D, Rosenberg L, Miettinen OS, Stolley PD, Knapp RC, Leavitt T, Watring WG, Rosenshein NB, Lewis JL, Schottenfeld D, Engle RL.
    N Engl J Med; 1980 Oct 30; 303(18):1045-7. PubMed ID: 7421893
    [Abstract] [Full Text] [Related]

  • 2. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS, Sayvetz TA.
    N Engl J Med; 1980 Mar 06; 302(10):551-4. PubMed ID: 7351890
    [Abstract] [Full Text] [Related]

  • 3. Oral contraceptives and endometrial cancer.
    Cole P.
    N Engl J Med; 1980 Mar 06; 302(10):575-6. PubMed ID: 7351894
    [Abstract] [Full Text] [Related]

  • 4. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL, Peterson HB.
    Contracept Technol Update; 1985 Jan 06; 6(1):7-12. PubMed ID: 12279918
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptives and neoplasia.
    Stubblefield PG.
    J Reprod Med; 1984 Jul 06; 29(7 Suppl):524-9. PubMed ID: 6481705
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC, Kay CR.
    Br J Gen Pract; 1998 Oct 06; 48(435):1657-62. PubMed ID: 10071398
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined pills may decrease endometrial cancer risk; sequentials may increase it.
    Fam Plann Perspect; 1980 Oct 06; 12(3):162. PubMed ID: 7398868
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC.
    Gynecol Oncol; 2006 Nov 06; 103(2):535-40. PubMed ID: 16740300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
    Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT.
    Epidemiology; 2008 Mar 06; 19(2):237-43. PubMed ID: 18223481
    [Abstract] [Full Text] [Related]

  • 19. Oral contraceptives and endometrial cancer.
    Jick SS, Walker AM, Jick H.
    Obstet Gynecol; 1993 Dec 06; 82(6):931-5. PubMed ID: 8233267
    [Abstract] [Full Text] [Related]

  • 20. The epidemiology of endometrial cancer in young women.
    Henderson BE, Casagrande JT, Pike MC, Mack T, Rosario I, Duke A.
    Br J Cancer; 1983 Jun 06; 47(6):749-56. PubMed ID: 6860544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.